NTEC Announces MedVentures 2010 Conference Date - July 21st 2010
(FRISCO, TEXAS / MAY 28,
2010) - The North Texas Enterprise Center (NTEC), a nonprofit
organization dedicated to assisting medtech and cleantech start-up
companies announced today its annual MedVentures 2010 Conference
will be held July 21st from 7am to 4:30pm at the Embassy Suites
Frisco Conference Center, 7600 John Q Hammons Drive in Frisco,
Texas. This is an annual, regional, early stage investment
conference and company showcase focused on the medical technology
sector. This sector includes medical instruments and devices,
diagnostic equipment, medical therapeutic devices, medical
monitoring equipment, and other health related products. The
program includes an angel investor panel discussion, venture
capital panel discussion and a showcase of eight pre-qualified
emerging medical technology companies.
"The purpose of the
conference is to connect quality emerging medtech companies seeking
capital with investors that focus on this industry sector," said
Dr. Hubert Zajicek, Senior Director at NTEC. "In addition to
investors, the conference delivers timely educational content to
medtech entrepreneurs and industry professionals."
Dr. Zajicek explained
that MedVentures 2010 provides a "trade show" venue for vendors and
service providers seeking to exhibit their capabilities at the
conference.
"MedVentures 2010 is
NTEC's premier event and fulfills an important need in our region,"
said Larry Calton, Executive Director at NTEC. "Equity funding for
seed and early stage companies has decreased dramatically over the
last five years. Although the global economy and specifically, the
US recession, has negatively impacted investors, high quality start
ups continue to attract capital." Furthermore, Mr. Calton expects
that MedVentures 2010 will beat last year's attendance record of
over 300. "The program, which is a full day long, will feature more
presenting companies, more program content and additional
networking opportunities," he said.
The following medtech
investors are expected to speak or attend the MedVentures 2010:
Santé Ventures, PTV Sciences, Sevin Rosen Funds, Prolog Ventures,
Rivervest Ventures, H.I.G. BioVentures, Chrysalis Ventures,
Scientific Healthcare Ventures, Hunt BioVentures, InterWest
Partners, Texas Emerging Technology Fund, the North Texas Angel
Network, Eyes of Texas Partners, Lone Star Angels, Central Texas
Angels and Texas Womens Ventures Fund. Additionally, numerous
individual angel investors and providers of alternative sources of
financing for early stage opportunities are expected to be in
attendance.
The NTEC MedVentures
2010 conference is being supported by the following industry
organizations: BioDFW, BioHouston, N.TX RCIC, Dallas Regional
Chamber, The Institute for Innovation and Entrepreneurism at UTD,
TECH Fort Worth, Dallas Technology Business Council, TechAmerica,
and the Government Insider.
WHO SHOULD
ATTEND
Emerging company
entrepreneurs seeking capital
Investors interested in
meeting quality medtech entrepreneurs
Professionals looking to
expand their medtech knowledge and network
Vendors and service providers
interested in showcasing their offerings
Healthcare service industry
professionals interested in innovative medical technologies
2009 MEDVENTURES SET
THE STAGE FOR AN EVEN MORE SUCCESSFUL 2010 EVENT
The six finalist presenting
companies from last year's event have raised almost $15 million
since the conference. This is remarkable since all but one of these
are pre-revenue companies. Dr. Zajicek said that it is a strong
testament to the quality of the presenting companies at the
MedVentures events and bodes well for anyone who gets chosen to
present this year.
"It is a sign of the
times that almost half of this money was raised through successful
grant writing and partnerships that allow these companies to move
forward with their research and development without diluting their
existing shareholders," Dr. Zajicek added. "Furthermore, two of
these companies, Microtransponder and Stellarray, are also ETF
recipients."
Here is a list of
accomplishments since July 2009 as reported by the companies:
- Hygieia
received 510(k) clearance for their glucose monitoring platform,
and launched a third clinical trial after successful completion of
#2;
- Microtransponder's issuance
of a critical patent to their technology as well as significant
grant and angel funding;
- Stellarray's successful
grant issuances, prototype of a blood transfusion irradiator and
R&D contract to work on a wastewater treatment solution;
- MDConnection's 1st
million of revenue;
- Sironics completed the
production prototype;
- Traumatec is continuing
their major Baylor study and is getting ready to participate
in three new device studies dealing with traumatic brain injury,
stroke and emergency rescue respectively.
NTEC is experiencing a
significant increase in interest to present at this year's
conference and as a result, increased the presenting company spots
to 8, with a possibility to go up to 10.
For more information about
exhibiting and/or registering for MedVentures 2010, visit the event
web site at www.ntec-inc.oeg/medventures2010